Radiopharm Theranostics

Corporate Governance

ASX Announcements

Updates

Home

Manrope

Click here to visit our dedicated Entitlement Offer (NREO) page for all the information you need to participate. 

Radiopharm Therapeutics CEO, Riccardo Caneveri, introduces the Non-Renounceable Entitlement Offer to raise approximately $10 million. Eligible shareholders in Australia and New Zealand will be invited to participate in the Entitlement Offer which will open on Wednesday, 8 November 2023 and close at 5:00pm (Sydney time) on Friday, 24 November 2023.

For more information, visit Radiopharm's dedicated Entitlement Offer website.

Radiopharm Entitlement Offer